Radiographic findings |
Number of cases (percentage) |
Consolidation |
27 (77.1%) |
Ground glass opacity |
24 (68.6%) |
Isolated ground glass opacity |
6 (17.1%) |
Isolated consolidation |
9 (25.7%) |
Both consolidation and ground glass opacity |
18 (51.4%) |
Interstitial pattern |
2 (5.7%) |
Nodular pattern |
2 (5.7%) |
Pleural effusion |
3 (8.6%) |
Prominent hila (hilar lymphadenopathy) |
15 (42.9%) |
Pneumothorax |
1( patient expired) |
Sides involved: |
|
Unilateral |
5 (14.3%), 2 right, 3 left |
Bilateral |
30 (85.7%), predominance 9 right, 3 left, 18
(51.4%) bilateral equal involvement |
Predominance of side involved |
11 (31.4%) right, 6 (17.1%) left |
Zonal predominance: |
|
All zones |
6 (17.1%) |
Mid and lower zones |
18 (51.4%) |
Mid zone |
4 (11.4%) |
Lower zone |
6 (17.1%) |
Upper and mid zone |
1 (2.9%) |
Mid zone, lower zone or combined mid and lower
zone |
28 (80%) |
Central and peripheral distribution: |
|
Central predominance |
14 (40%) |
Peripheral predominance |
9 (25.7%) |
Almost equal involvement |
12 (34.3%) |
Authors |
Total number of
cases with abnormal CXR |
Bilateral |
Unilateral |
Zonal dominance |
Distribution
central/peripheral |
Adverse outcome
(deaths) |
McEwen RE [2] |
12(23.1%) |
6(50%) |
6(3 rt, 3 lt) |
basal
|
Not noted |
1 (8.3%) |
Abbo[9] L |
39 |
23(59%) |
16(41%) |
21(54%) lz |
None |
6 (4%) |
Min Jeong Choi [8]
(pediatrics) |
26 (6%) |
19 ( 73%) |
7 (27%) |
lz, 22 (85%) |
Not noted |
0 (no deaths) |
Aviram l[7] |
39 (40%) |
24 (62%) |
15 (38%) |
mz 26 (66.7%) right, 24 (62%) left |
peri 77% |
4 (10.2%) |
Present study(
Total) |
35(83.3%) |
30(85.7%) |
5(14..3%) |
18(51.4%) mz, lz |
14(40%) cen, 9(25.7%) peri, |
12 (34.2%) |
Abbo L[9] (
pediatric) |
19 |
15(81%) |
4(19%) |
lz 8(42%) |
None |
Not mentioned |
Present study
(pediatric) |
11 |
9(81.8%) |
2(18.2%) |
5(45.5%) mz and lz |
cen 9(81.8%) |
2 (18.2%) |
Abbo L [9]( adult) |
39 |
23(59%) |
16(41%) |
lz 21(54%) |
cen 6(15%) |
Not mentioned |
Present study adult |
24 |
21(87.5%) |
3(12.5%) |
13(54.2%) mz and lz |
Both 11(45.8%) |
10(41.7%) |
Study |
Consolidation |
Ground glass opacity |
Interstitial |
Nodule |
Pleural. effusion |
Lymphadenopathy |
bilateral
multizonal involvement |
McEwen RE [2] |
12 (100%) |
Not noted |
nil |
Not noted |
6 (50%) |
Not noted |
3 (25%) |
Min Jeong Choi [8](pediatric) |
22 (85%) |
2 (8%) |
25 (96%) |
Not noted |
11 (42%) |
Not noted |
Not noted |
Present study( total) |
27 (77.1%) |
24 (68.6%) |
2 (5.7%) |
2 (5.7%) |
3 (8.6%) |
15 (42.9%) |
17 (48.6%) |
Abbo L[9] |
32 (82%) |
9 |
4 |
2 |
1 |
1 |
Not noted |
Aviram [7] |
23 (59%) |
27 (69%) |
Not mentioned |
11 (28%) |
3 (8%) |
not mentioned |
72% |
Abbo L [9](pediatric) |
12 (29%) |
1 (2%) |
0 |
0 |
0 |
1 (2%) |
Not noted |
Present study( pediatric) |
8 (72.7%) |
6 (54.5%) |
1 (9.1%) |
1 (9.1%) |
1 (9.1%) |
4 (36.4%) |
3 (27.3%) |
Abbo L [9]adult) |
20 (25%) |
8(10%) |
4 (5%) |
2(3%) |
1(1%) |
0 |
Not noted |
Present study (adult) |
19 (79.2%) |
18 (75.0%) |
1 (4.2%) |
1 (4.2%) |
2 (8.3%) |
11 (45.8%) |
14 (58.3%) |